In the News

1857 News Items found
Pictured: Douglas Levine and Petar Jelinic
In the Lab
Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
Pictured: Bayard Clarkson
Feature
Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.
Pictured: David Scheinberg
Feature
The MD Anderson Cancer Center presented its annual award to Dr. Scheinberg in recognition of his pioneering work in developing chemotherapeutic agents for leukemia and other cancers.
Pictured: Kathryn Anderson
Feature
The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics.
Pictured: Neural stem cells
Feature
Research at Memorial Sloan Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.
Pictured: Nikola Pavletich and Alexander Rudensky
Honors
Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.
Pictured: Graduates
Event
As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.
Pictured: Jedd Wolchok and James Allison
In the News
In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
Pictured: Michael Kharas
Profile
As a child, Michael Kharas knew that he wanted to “be making the drugs doctors use to cure people.” Today he investigates molecular processes that stem cells and tumor cells have in common – in the hopes of uncovering insights for treatments for cancer and other diseases.
Pictured: T cells on surface on thymus
In the Lab
A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.